Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-17

Clinical Trial Update: Effects of Antimuscarinics on Cognition in Spinal Cord Injury

View source ↗

Summary

Completed clinical trial evaluating the effects of antimuscarinic drugs on cognition in people with spinal cord injury. The study explores potential cognitive s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • antimuscarinic agents

Snippet

Sponsor: Swiss Paraplegic Research, Nottwil | Conditions: Mild Cognitive Impairment, Spinal Cord Injuries | Status: COMPLETED